These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32217467)

  • 41. Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers.
    Sousa MM; Ferrão J; Fernandes R; Guimarães A; Geraldes JB; Perdigoto R; Tomé L; Mota O; Negrão L; Furtado AL; Saraiva MJ
    Lab Invest; 2004 Jul; 84(7):865-73. PubMed ID: 15122304
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute-onset chronic inflammatory demyelinating polyneuropathy: An electrodiagnostic study.
    Anadani M; Katirji B
    Muscle Nerve; 2015 Nov; 52(5):900-5. PubMed ID: 25809534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are electrophysiological criteria useful in distinguishing childhood demyelinating neuropathies?
    Potulska-Chromik A; Ryniewicz B; Aragon-Gawinska K; Kabzinska D; Seroka A; Lipowska M; Kaminska AM; Kostera-Pruszczyk A
    J Peripher Nerv Syst; 2016 Mar; 21(1):22-6. PubMed ID: 26663344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiology of Transthyretin Familial Amyloid Polyneuropathy in Portugal: A Nationwide Study.
    Inês M; Coelho T; Conceição I; Duarte-Ramos F; de Carvalho M; Costa J
    Neuroepidemiology; 2018; 51(3-4):177-182. PubMed ID: 30153683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progression of transthyretin (TTR) amyloidosis in donors and recipients after domino liver transplantation-a prospective single-center cohort study.
    Vollmar J; Schmid JC; Hoppe-Lotichius M; Barreiros AP; Azizi M; Emrich T; Geber C; Schad A; Weyer V; Otto G; Heise M; Mittler J; Birklein F; Lang H; Galle PR; Zimmermann T
    Transpl Int; 2018 Nov; 31(11):1207-1215. PubMed ID: 30091268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Annual electrocardiograms consistent with silent progression of cardiac involvement in sporadic familial amyloid polyneuropathy: a case report.
    Takigawa M; Hashimura K; Ishibashi-Ueda H; Yamada N; Kiso K; Nanasato M; Yoshida Y; Hirayama H
    Intern Med; 2010; 49(2):139-44. PubMed ID: 20075578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel transthyretin variant p.H110D (H90D) as a cause of familial amyloid polyneuropathy in a large Irish kindred.
    Jimenez-Zepeda VH; Bahlis NJ; Gilbertson J; Rendell N; Porcari R; Lachmann HJ; Gillmore JD; Hawkins PN; Rowczenio DM
    Amyloid; 2015 Mar; 22(1):26-30. PubMed ID: 25430583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis.
    Obici L; Kuks JB; Buades J; Adams D; Suhr OB; Coelho T; Kyriakides T;
    Curr Opin Neurol; 2016 Feb; 29 Suppl 1(Suppl 1):S27-35. PubMed ID: 26734953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TTR-related amyloid neuropathy: clinical, electrophysiological and pathological findings in 15 unrelated patients.
    Luigetti M; Conte A; Del Grande A; Bisogni G; Madia F; Lo Monaco M; Laurenti L; Obici L; Merlini G; Sabatelli M
    Neurol Sci; 2013 Jul; 34(7):1057-63. PubMed ID: 22592564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP.
    Parman Y; Adams D; Obici L; Galán L; Guergueltcheva V; Suhr OB; Coelho T;
    Curr Opin Neurol; 2016 Feb; 29 Suppl 1(Suppl 1):S3-S13. PubMed ID: 26734951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: Does genetic risk affect family functioning?
    Lopes A; Rodrigues C; Fonseca I; Sousa A; Branco M; Coelho T; Sequeiros J; Freitas P
    Clin Genet; 2018 Nov; 94(5):401-408. PubMed ID: 30019395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP.
    Sommer C; Koch S; Lammens M; Gabreels-Festen A; Stoll G; Toyka KV
    Neurology; 2005 Dec; 65(12):1924-9. PubMed ID: 16380614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel methods for detecting amyloidogenic proteins in transthyretin related amyloidosis.
    Ando Y; Ueda M
    Front Biosci; 2008 May; 13():5548-58. PubMed ID: 18508604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study.
    Ando Y; Sekijima Y; Obayashi K; Yamashita T; Ueda M; Misumi Y; Morita H; Machii K; Ohta M; Takata A; Ikeda S
    J Neurol Sci; 2016 Mar; 362():266-71. PubMed ID: 26944161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Familial amyloid polyneuropathy].
    Yamashita T; Ando Y; Uchino M
    Brain Nerve; 2011 Jun; 63(6):583-95. PubMed ID: 21613661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Transthyretin familial amyloid polyneuropathy].
    Kopishinskaya SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):82-89. PubMed ID: 30499502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electrophysiological parameters that contribute to the pathogenesis of familial amyloid polyneuropathy caused by transthyretin mutations.
    Lai HJ; Lai WT; Jin L; Kuo KT; Lee MJ
    J Neurol Sci; 2020 Jun; 413():116810. PubMed ID: 32247966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum transthyretin monomer in patients with familial amyloid polyneuropathy.
    Sekijima Y; Tokuda T; Kametani F; Tanaka K; Maruyama K; Ikeda S
    Amyloid; 2001 Dec; 8(4):257-62. PubMed ID: 11791618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area.
    Takahashi R; Ono K; Shibata S; Nakamura K; Komatsu J; Ikeda Y; Ikeda T; Samuraki M; Sakai K; Iwasa K; Kayano D; Yamada M
    J Neurol Sci; 2014 Oct; 345(1-2):231-5. PubMed ID: 25060417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peripheral Blood Cell Gene Expression Diagnostic for Identifying Symptomatic Transthyretin Amyloidosis Patients: Male and Female Specific Signatures.
    Kurian SM; Novais M; Whisenant T; Gelbart T; Buxbaum JN; Kelly JW; Coelho T; Salomon DR
    Theranostics; 2016; 6(11):1792-809. PubMed ID: 27570551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.